The importance of diffusion apparent diffusion coefficient values in the evaluation of soft tissue sarcomas after treatment
- PMID: 34136047
- PMCID: PMC8186304
- DOI: 10.5114/pjr.2021.106413
The importance of diffusion apparent diffusion coefficient values in the evaluation of soft tissue sarcomas after treatment
Abstract
Purpose: In our study, we aimed to show the efficiency of diffusion-weighted images at different b-values and apparent diffusion coefficient (ADC) values in the differentiation of recurrent tumours from post-treatment tissue changes.
Material and methods: The conventional and diffusion magnetic resonance images (MRIs) of 42 patients operated for soft tissue sarcomas between June 2012 and March 2015 followed up with MRIs that were evaluated by 2 radiologists retrospectively. Diffusion MRIs were acquired at 4 different b-values (50, 400, 800, 1000 s/mm2). The lesions were classified according to conventional MRI findings as post-treatment changes and recurrent tumours.
Results: When the patient group with recurrent tumours was compared with the patient group with postoperative changes the ADC calculations were statistically significantly lower for the recurrent tumours at all b-levels (p < 0.001 for all b-levels). The sensitivity of b-50 values lower than 3.01 × 103 mm2/s in showing recurrent tumours was 100% and the specificity was 77.78%. The sensitivity of b-400 values lower than 2.1 × 103 mm2/s in showing recurrent tumours was 80% and the specificity was 96.3%. The sensitivity of b-800 values lower than 2.26 × 103 mm2/s in showing recurrent tumours was 100% and the specificity was 88.89%. The sensitivity of b-1000 values lower than 2 × 103 mm2/s in showing recurrent tumours was 93.3% and the specificity was 92.5%.
Conclusions: The ADC values obtained from diffusion-weighted images have high sensitivity and specificity in differentiating recurring soft tissue sarcomas during monitoring after treatment from postoperative changes.
Keywords: MR imaging; diffusion-weighted magnetic resonance imaging; posttreatment changes; recurrent sarcomas; soft tissue tumours.
© Pol J Radiol 2021.
Conflict of interest statement
The authors report no conflict of interest.
Figures



References
-
- Landis SH, Wurray T, Bolden S, et al. . Cancer statistics 1999. Cancer J Clin 1999; 49: 8-31. - PubMed
-
- Potter DA, Glenn J, Kinsella T, et al. . Patterns of recurrence in patients with highgrade soft tissue sarcomas. J Clin Oncol 1985; 3: 353-366. - PubMed
-
- Lewis JJ, Leung D, Heslin M, et al. . Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol 1997; 15: 646-652. - PubMed
-
- Cormier JN, Pollock RE. Soft tissue sarcomas. Cancer J Clin 2004; 54: 94-109. - PubMed
LinkOut - more resources
Full Text Sources